Breaking News Instant updates and real-time market news.

VOYA

Voya Financial

$60.92 /

-0.51 (-0.83%)

05:00
09/30/22
09/30
05:00
09/30/22
05:00

Voya Financial upgraded to Overweight from Neutral at Piper Sandler

Piper Sandler analyst John Barnidge upgraded Voya Financial to Overweight from Neutral with a price target of $70, up from $65. The analyst sees the company as a "net beneficiary" from higher inflation. Voya's purchase of Allianz Global Investors U.S. funds brings enhanced distribution with limited currency exposure and its valuation is materially lower than life insurers with sizable asset management operations, Barnidge tells investors in a research note.

OTHER BREAKING NEWS FROM THE FLY

Hot Stocks
Iovance rallies after director buys $65M worth of shares » 18:46
12/02/22
12/02
18:46
12/02/22
18:46
IOVA

Iovance Biotherapeutics

$6.85 /

+0.44 (+6.87%)

Iovance Biotherapeutics…

Iovance Biotherapeutics Director Wayne Rothbaum disclosed the purchase of 10M shares at a price of $6.50. The $65M of shares were purchased on December 2. Rothbaum now owns 18,067,333 shares of Iovance, which is up 10% to $7.49 in after-hours trading following the disclosure in a regulatory filing.

ShowHide Related Items >><<
IOVA Iovance Biotherapeutics
$6.85 /

+0.44 (+6.87%)

IOVA Iovance Biotherapeutics
$6.85 /

+0.44 (+6.87%)

11/21/22 JMP Securities
Iovance Biotherapeutics price target lowered to $21 from $25 at JMP Securities
11/20/22 Piper Sandler
Iovance Biotherapeutics price target lowered to $11 from $13 at Piper Sandler
11/18/22 Chardan
Iovance Biotherapeutics price target lowered to $29 from $30 at Chardan
11/18/22 Oppenheimer
Iovance price target lowered to $25 from $27 at Oppenheimer
IOVA Iovance Biotherapeutics
$6.85 /

+0.44 (+6.87%)

IOVA Iovance Biotherapeutics
$6.85 /

+0.44 (+6.87%)

Periodicals
Microsoft prepared to fight for Activision acquisition, Bloomberg reports » 18:02
12/02/22
12/02
18:02
12/02/22
18:02
MSFT

Microsoft

$255.05 /

+0.25 (+0.10%)

, ATVI

Activision Blizzard

$75.76 /

+0.585 (+0.78%)

Microsoft (MSFT) is…

Microsoft (MSFT) is prepared to fight for its proposed $69B takeover of Activision Blizzard (ATVI) if the U.S. FTC files a lawsuit aiming to block the transaction, Bloomberg's Dina Bass and Katharine Gemmell report, citing a person familiar with the matter. Microsoft has not had talks with the FTC about remedies or concessions meant to get the deal approved, the authors note. The FTC is wrapping up its probe into the deal and is anticipated to make a recommendation soon, the authors say.

ShowHide Related Items >><<
MSFT Microsoft
$255.05 /

+0.25 (+0.10%)

ATVI Activision Blizzard
$75.76 /

+0.585 (+0.78%)

MSFT Microsoft
$255.05 /

+0.25 (+0.10%)

12/01/22 BMO Capital
Okta price target raised to $69 from $58 at BMO Capital
12/01/22 Wedbush
Activision Blizzard added to Best Ideas List at Wedbush
11/29/22 Morgan Stanley
Microsoft demand should hold up better than investors fear, says Morgan Stanley
11/28/22 JPMorgan
Activision Blizzard price target lowered to $86 from $95 at JPMorgan
ATVI Activision Blizzard
$75.76 /

+0.585 (+0.78%)

11/28/22 Wells Fargo
Wells Fargo upgrades Activision Blizzard to Overweight with $95 price target
11/28/22 Morgan Stanley
Activision Blizzard upgraded to Overweight from Equal Weight at Morgan Stanley
MSFT Microsoft
$255.05 /

+0.25 (+0.10%)

ATVI Activision Blizzard
$75.76 /

+0.585 (+0.78%)

MSFT Microsoft
$255.05 /

+0.25 (+0.10%)

ATVI Activision Blizzard
$75.76 /

+0.585 (+0.78%)

MSFT Microsoft
$255.05 /

+0.25 (+0.10%)

MSFT Microsoft
$255.05 /

+0.25 (+0.10%)

ATVI Activision Blizzard
$75.76 /

+0.585 (+0.78%)

Hot Stocks
Warner Music director Benet sells 15,000 class A common shares » 17:48
12/02/22
12/02
17:48
12/02/22
17:48
WMG

Warner Music

$34.34 /

+0.1 (+0.29%)

In a regulatory filing,…

In a regulatory filing, Warner Music Group director Lincoln Benet disclosed the sale of 15,000 class A common shares of the company on November 30 at a price of $34.03 per share.

ShowHide Related Items >><<
WMG Warner Music
$34.34 /

+0.1 (+0.29%)

WMG Warner Music
$34.34 /

+0.1 (+0.29%)

11/25/22 Morgan Stanley
Warner Music price target raised to $38 from $31 at Morgan Stanley
11/23/22 Deutsche Bank
Warner Music price target raised to $37 from $30 at Deutsche Bank
11/23/22 JPMorgan
Warner Music price target raised to $39 from $34 at JPMorgan
11/23/22 BofA
Warner Music upgraded to Neutral at BofA after 'strong end to the year'
WMG Warner Music
$34.34 /

+0.1 (+0.29%)

  • 04
    Jan
  • 09
    Dec
WMG Warner Music
$34.34 /

+0.1 (+0.29%)

WMG Warner Music
$34.34 /

+0.1 (+0.29%)

Recommendations
Spirit Realty price target lowered to $50 from $52 at Truist » 17:40
12/02/22
12/02
17:40
12/02/22
17:40
SRC

Spirit Realty

$41.28 /

+0.375 (+0.92%)

Truist analyst Ki Bin Kim…

Truist analyst Ki Bin Kim lowered the firm's price target on Spirit Realty to $50 from $52 and keeps a Buy rating on the shares.

ShowHide Related Items >><<
SRC Spirit Realty
$41.28 /

+0.375 (+0.92%)

SRC Spirit Realty
$41.28 /

+0.375 (+0.92%)

11/14/22 BofA
Spirit Realty downgraded to Neutral at BofA in net lease REIT repositioning
11/14/22 BofA
Spirit Realty downgraded to Neutral from Buy at BofA
10/19/22 Oppenheimer
Spirit Realty initiated with a Perform at Oppenheimer
09/15/22 Truist
Truist views Store Capital deal as incremental positive read-through for Spirit Realty
SRC Spirit Realty
$41.28 /

+0.375 (+0.92%)

  • 13
    Jan
Recommendations
Agree Realty price target lowered to $80 from $84 at Truist » 17:39
12/02/22
12/02
17:39
12/02/22
17:39
ADC

Agree Realty

$70.78 /

+0.58 (+0.83%)

Truist analyst Ki Bin Kim…

Truist analyst Ki Bin Kim lowered the firm's price target on Agree Realty to $80 from $84 and keeps a Buy rating on the shares.

ShowHide Related Items >><<
ADC Agree Realty
$70.78 /

+0.58 (+0.83%)

ADC Agree Realty
$70.78 /

+0.58 (+0.83%)

10/18/22 JMP Securities
Agree Realty price target lowered to $75 from $82 at JMP Securities
10/04/22 Raymond James
Agree Realty price target lowered to $80 from $85 at Raymond James
08/22/22 Truist
Agree Realty price target raised to $84 from $77 at Truist
08/04/22 RBC Capital
Agree Realty price target raised to $83 from $76 at RBC Capital
ADC Agree Realty
$70.78 /

+0.58 (+0.83%)

  • 29
    Sep
  • 26
    May
  • 09
    Dec
ADC Agree Realty
$70.78 /

+0.58 (+0.83%)

Recommendations
Safehold price target lowered to $33 from $46 at Truist » 17:38
12/02/22
12/02
17:38
12/02/22
17:38
SAFE

Safehold

$29.34 /

+0.79 (+2.77%)

Truist analyst Ki Bin Kim…

Truist analyst Ki Bin Kim lowered the firm's price target on Safehold to $33 from $46 and keeps a Hold rating on the shares.

ShowHide Related Items >><<
SAFE Safehold
$29.34 /

+0.79 (+2.77%)

SAFE Safehold
$29.34 /

+0.79 (+2.77%)

09/23/22 SMBC Nikko
Safehold downgraded to Neutral from Outperform at SMBC Nikko
08/12/22 Mizuho
Safehold upgraded to Buy from Neutral at Mizuho
08/11/22 Truist
iStar tax-free combination to internalize Safehold management team, says Truist
07/15/22 Morgan Stanley
Safehold price target lowered to $85 from $100 at Morgan Stanley
SAFE Safehold
$29.34 /

+0.79 (+2.77%)

  • 03
    Mar
SAFE Safehold
$29.34 /

+0.79 (+2.77%)

Recommendations
Whitestone REIT price target raised to $10 from $9 at Truist » 17:38
12/02/22
12/02
17:38
12/02/22
17:38
WSR

Whitestone REIT

$9.81 /

+0.075 (+0.77%)

Truist analyst Anthony…

Truist analyst Anthony Hau raised the firm's price target on Whitestone REIT to $10 from $9 and keeps a Hold rating on the shares.

ShowHide Related Items >><<
WSR Whitestone REIT
$9.81 /

+0.075 (+0.77%)

WSR Whitestone REIT
$9.81 /

+0.075 (+0.77%)

08/30/22 Truist
Truist starts Whitestone REIT at Hold, sees challenging 2023 setup
08/30/22 Truist
Whitestone REIT initiated with a Hold at Truist
08/05/22 B. Riley
Whitestone REIT price target lowered to $11.50 from $13 at B. Riley
07/07/22 JMP Securities
Whitestone REIT upgraded to Outperform from Market Perform at JMP Securities
Recommendations
Site Centers price target lowered to $14 from $15 at Truist » 17:37
12/02/22
12/02
17:37
12/02/22
17:37
SITC

Site Centers

$13.53 /

-0.045 (-0.33%)

Truist analyst Ki Bin Kim…

Truist analyst Ki Bin Kim lowered the firm's price target on Site Centers to $14 from $15 and keeps a Hold rating on the shares.

ShowHide Related Items >><<
SITC Site Centers
$13.53 /

-0.045 (-0.33%)

11/11/22 Mizuho
Site Centers price target lowered to $14 from $17 at Mizuho
10/07/22 Piper Sandler
Site Centers price target lowered to $14 from $17 at Piper Sandler
09/27/22 Evercore ISI
Site Centers price target lowered to $15 from $16 at Evercore ISI
08/16/22 Mizuho
Site Centers upgraded to Buy from Neutral at Mizuho
SITC Site Centers
$13.53 /

-0.045 (-0.33%)

SITC Site Centers
$13.53 /

-0.045 (-0.33%)

Conference/Events
Caesarstone management to meet virtually with Benchmark » 17:31
12/02/22
12/02
17:31
12/02/22
17:31
CSTE

Caesarstone

$6.27 /

-0.12 (-1.88%)

Virtual Meetings to be…

Virtual Meetings to be held with CEO Dagim and CFO Trost on December 7-8 hosted by Benchmark.

ShowHide Related Items >><<
Syndicate
Axsome Therapeutics files automatic mixed securities shelf  17:30
12/02/22
12/02
17:30
12/02/22
17:30
AXSM

Axsome Therapeutics

$76.93 /

+4.89 (+6.79%)

 
ShowHide Related Items >><<
AXSM Axsome Therapeutics
$76.93 /

+4.89 (+6.79%)

AXSM Axsome Therapeutics
$76.93 /

+4.89 (+6.79%)

11/29/22 Morgan Stanley
Axsome Therapeutics price target raised to $86 from $73 at Morgan Stanley
11/28/22 Ladenburg
Axsome's positive data may provide path for earlier sNDA filing, says Ladenburg
11/28/22 Guggenheim
Axsome Therapeutics study met primary, secondary endpoints, says Guggenheim
11/09/22 Mizuho
Axsome Therapeutics price target raised to $80 from $76 at Mizuho
AXSM Axsome Therapeutics
$76.93 /

+4.89 (+6.79%)

AXSM Axsome Therapeutics
$76.93 /

+4.89 (+6.79%)

AXSM Axsome Therapeutics
$76.93 /

+4.89 (+6.79%)

Conference/Events
eBay management to meet virtually with Benchmark » 17:28
12/02/22
12/02
17:28
12/02/22
17:28
EBAY

eBay

$45.24 /

+0.06 (+0.13%)

Virtual Meeting to be…

Virtual Meeting to be held on December 5 at 12:15 pm hosted by Benchmark.

ShowHide Related Items >><<
EBAY eBay
$45.24 /

+0.06 (+0.13%)

EBAY eBay
$45.24 /

+0.06 (+0.13%)

11/15/22 MoffettNathanson
eBay initiated with a Market Perform at MoffettNathanson
11/03/22 Benchmark
eBay price target lowered to $62 from $66 at Benchmark
11/03/22 Baird
eBay price target lowered to $55 from $60 at Baird
11/03/22 Barclays
eBay price target lowered to $56 from $59 at Barclays
EBAY eBay
$45.24 /

+0.06 (+0.13%)

EBAY eBay
$45.24 /

+0.06 (+0.13%)

EBAY eBay
$45.24 /

+0.06 (+0.13%)

EBAY eBay
$45.24 /

+0.06 (+0.13%)

Syndicate
Imperial Petroleum files $500M mixed securities shelf  17:27
12/02/22
12/02
17:27
12/02/22
17:27
IMPP

Imperial Petroleum

/

+

 
ShowHide Related Items >><<
IMPP Imperial Petroleum
/

+

IMPP Imperial Petroleum
/

+

  • 21
    Mar
IMPP Imperial Petroleum
/

+

Periodicals
Ubisoft's next 'Assassin's Creed' out August 2023, Insider Gaming says » 17:27
12/02/22
12/02
17:27
12/02/22
17:27
UBSFY

Ubisoft

$5.95 /

+0.22 (+3.84%)

Ubisoft's upcoming…

Ubisoft's upcoming title "Assassin's Creed Mirage" is currently scheduled to release in August 2023, Insider Gaming's Tom Henderson reports. The date, which has not been publicly announced, is tentative and subject to change, the author notes. Reference Link

ShowHide Related Items >><<
UBSFY Ubisoft
$5.95 /

+0.22 (+3.84%)

UBSFY Ubisoft
$5.95 /

+0.22 (+3.84%)

11/02/22 Morgan Stanley
Ubisoft price target lowered to EUR 52 from EUR 57 at Morgan Stanley
10/28/22 Credit Suisse
Ubisoft price target lowered to EUR 40 from EUR 48.50 at Credit Suisse
10/28/22 Societe Generale
Ubisoft price target lowered to EUR 50 from EUR 55 at Societe Generale
10/28/22 Goldman Sachs
Ubisoft upgraded to Neutral from Sell at Goldman Sachs
UBSFY Ubisoft
$5.95 /

+0.22 (+3.84%)

UBSFY Ubisoft
$5.95 /

+0.22 (+3.84%)

UBSFY Ubisoft
$5.95 /

+0.22 (+3.84%)

Hot Stocks
Cushman & Wakefield to replace Diebold in S&P 600 at open on 12/19  17:22
12/02/22
12/02
17:22
12/02/22
17:22
CWK

Cushman & Wakefield

$11.97 /

+0.09 (+0.76%)

, DBD

Diebold

$2.09 /

-0.01 (-0.48%)

 
ShowHide Related Items >><<
DBD Diebold
$2.09 /

-0.01 (-0.48%)

CWK Cushman & Wakefield
$11.97 /

+0.09 (+0.76%)

CWK Cushman & Wakefield
$11.97 /

+0.09 (+0.76%)

07/22/22 Raymond James
Cushman & Wakefield removed from Analyst Current Favorites list at Raymond James
04/21/22 Citi
Cushman & Wakefield price target lowered to $21 from $23 at Citi
04/05/22 Goldman Sachs
Cushman & Wakefield initiated with a Buy at Goldman Sachs
03/10/22 Wolfe Research
Cushman & Wakefield price target lowered to $28 from $44 at Wolfe Research
DBD Diebold
$2.09 /

-0.01 (-0.48%)

10/24/22 DA Davidson
Diebold downgraded to Neutral from Buy at DA Davidson
08/12/22 JPMorgan
Diebold downgraded to Underweight from Neutral at JPMorgan
07/08/22 Wedbush
Wedbush upgrades Diebold, sees sales and earnings positioned to improve
07/08/22 Wedbush
Diebold upgraded to Outperform from Neutral at Wedbush
DBD Diebold
$2.09 /

-0.01 (-0.48%)

CWK Cushman & Wakefield
$11.97 /

+0.09 (+0.76%)

CWK Cushman & Wakefield
$11.97 /

+0.09 (+0.76%)

DBD Diebold
$2.09 /

-0.01 (-0.48%)

CWK Cushman & Wakefield
$11.97 /

+0.09 (+0.76%)

Hot Stocks
SJW Group to replace Cato Corp. in S&P 600 at open on 12/19  17:21
12/02/22
12/02
17:21
12/02/22
17:21
SJW

SJW Group

$74.37 /

+0.05 (+0.07%)

, CATO

Cato Corp.

$10.09 /

-0.06 (-0.59%)

 
ShowHide Related Items >><<
SJW SJW Group
$74.37 /

+0.05 (+0.07%)

SJW SJW Group
$74.37 /

+0.05 (+0.07%)

11/30/22 UBS
SJW Group initiated with a Buy at UBS
07/18/22 Barclays
SJW Group price target lowered to $65 from $72 at Barclays
06/02/22 Wells Fargo
Wells Fargo downgrades SJW Group to Equal Weight, lowers price target to $66
06/02/22 Wells Fargo
SJW Group downgraded to Equal Weight from Overweight at Wells Fargo
CATO Cato Corp.
$10.09 /

-0.06 (-0.59%)

SJW SJW Group
$74.37 /

+0.05 (+0.07%)

Hot Stocks
Agiliti to replace LL Flooring in S&P 600 at open on 12/19  17:21
12/02/22
12/02
17:21
12/02/22
17:21
AGTI

Agiliti

$17.44 /

+0.585 (+3.47%)

, LL

LL Flooring

$6.93 /

+0.07 (+1.02%)

 
ShowHide Related Items >><<
LL LL Flooring
$6.93 /

+0.07 (+1.02%)

AGTI Agiliti
$17.44 /

+0.585 (+3.47%)

11/15/22 Raymond James
Agiliti price target lowered to $20 from $22 at Raymond James
11/13/22 Citi
Agiliti price target lowered to $21 from $24 at Citi
08/15/22 Raymond James
Agiliti price target lowered to $22 from $25 at Raymond James
04/06/22 BMO Capital
Agiliti price target raised to $28 from $22 at BMO Capital
LL LL Flooring
$6.93 /

+0.07 (+1.02%)

LL LL Flooring
$6.93 /

+0.07 (+1.02%)

AGTI Agiliti
$17.44 /

+0.585 (+3.47%)

AGTI Agiliti
$17.44 /

+0.585 (+3.47%)

Hot Stocks
NuVasive to replace Tupperware Brands in S&P 600 at open on 12/19  17:20
12/02/22
12/02
17:20
12/02/22
17:20
NUVA

NuVasive

$39.98 /

-0.135 (-0.34%)

, TUP

Tupperware Brands

$4.66 /

+0.055 (+1.19%)

 
ShowHide Related Items >><<
TUP Tupperware Brands
$4.66 /

+0.055 (+1.19%)

NUVA NuVasive
$39.98 /

-0.135 (-0.34%)

NUVA NuVasive
$39.98 /

-0.135 (-0.34%)

11/10/22 Cowen
NuVasive price target lowered to $50 from $65 at Cowen
11/10/22 Wells Fargo
NuVasive price target lowered to $47 from $62 at Wells Fargo
11/10/22 Piper Sandler
NuVasive price target lowered to $50 from $60 at Piper Sandler
10/18/22 Barclays
Barclays starts medical devices with Positive view, Boston Scientific top pick
TUP Tupperware Brands
$4.66 /

+0.055 (+1.19%)

11/03/22 DA Davidson
Tupperware Brands price target lowered to $4.50 from $10 at DA Davidson
10/05/22 Citi
Tupperware Brands price target lowered to $8 from $11.50 at Citi
08/04/22 Citi
Tupperware Brands price target raised to $11.50 from $8 at Citi
08/02/22 Citi
Tupperware Brands transferred with Neutral rating at Citi
TUP Tupperware Brands
$4.66 /

+0.055 (+1.19%)

NUVA NuVasive
$39.98 /

-0.135 (-0.34%)

TUP Tupperware Brands
$4.66 /

+0.055 (+1.19%)

NUVA NuVasive
$39.98 /

-0.135 (-0.34%)

TUP Tupperware Brands
$4.66 /

+0.055 (+1.19%)

Hot Stocks
Semtech to replace Diversified Healthcare Trust in S&P 600 at open on 12/19  17:19
12/02/22
12/02
17:19
12/02/22
17:19
SMTC

Semtech

$29.36 /

-0.47 (-1.58%)

, DHC

Diversified Healthcare Trust

/

+

 
ShowHide Related Items >><<
SMTC Semtech
$29.36 /

-0.47 (-1.58%)

DHC Diversified Healthcare Trust
/

+

SMTC Semtech
$29.36 /

-0.47 (-1.58%)

12/01/22 Cowen
Semtech price target lowered to $33 from $43 at Cowen
12/01/22 Benchmark
Semtech price target lowered to $45 from $65 at Benchmark
12/01/22 Susquehanna
Semtech price target lowered to $32 from $34 at Susquehanna
11/30/22 Piper Sandler
Semtech price target lowered to $45 from $60 at Piper Sandler
DHC Diversified Healthcare Trust
/

+

05/09/22 B. Riley
Diversified Healthcare Trust price target lowered to $5 from $6 at B. Riley
02/25/22 B. Riley
Diversified Healthcare Trust price target lowered to $6 from $7 at B. Riley
02/01/22 B. Riley
Diversified Healthcare Trust price target raised to $7 from $6 at B. Riley
01/03/22 B. Riley
iStar, Aspen Aerogels among B. Riley's top 25 stock picks for 2022
SMTC Semtech
$29.36 /

-0.47 (-1.58%)

SMTC Semtech
$29.36 /

-0.47 (-1.58%)

SMTC Semtech
$29.36 /

-0.47 (-1.58%)

Hot Stocks
CubeSmart to replace NuVasive in S&P 400 at open on 12/19  17:19
12/02/22
12/02
17:19
12/02/22
17:19
CUBE

CubeSmart

$41.82 /

+0.39 (+0.94%)

, NUVA

NuVasive

$39.98 /

-0.135 (-0.34%)

 
ShowHide Related Items >><<
NUVA NuVasive
$39.98 /

-0.135 (-0.34%)

CUBE CubeSmart
$41.82 /

+0.39 (+0.94%)

10/17/22 UBS
CubeSmart initiated with a Buy at UBS
09/19/22 Evercore ISI
CubeSmart price target lowered to $53 from $54 at Evercore ISI
08/22/22 Truist
CubeSmart price target raised to $53 from $48 at Truist
08/16/22 Raymond James
CubeSmart price target raised to $58 from $52 at Raymond James
NUVA NuVasive
$39.98 /

-0.135 (-0.34%)

11/10/22 Cowen
NuVasive price target lowered to $50 from $65 at Cowen
11/10/22 Wells Fargo
NuVasive price target lowered to $47 from $62 at Wells Fargo
11/10/22 Piper Sandler
NuVasive price target lowered to $50 from $60 at Piper Sandler
10/18/22 Barclays
Barclays starts medical devices with Positive view, Boston Scientific top pick
NUVA NuVasive
$39.98 /

-0.135 (-0.34%)

CUBE CubeSmart
$41.82 /

+0.39 (+0.94%)

NUVA NuVasive
$39.98 /

-0.135 (-0.34%)

CUBE CubeSmart
$41.82 /

+0.39 (+0.94%)

Hot Stocks
Allegro MicroSystems to replace Semtech in S&P 400 at open on 12/19  17:18
12/02/22
12/02
17:18
12/02/22
17:18
ALGM

Allegro MicroSystems

$31.51 /

+0.37 (+1.19%)

, SMTC

Semtech

$29.36 /

-0.47 (-1.58%)

 
ShowHide Related Items >><<
SMTC Semtech
$29.36 /

-0.47 (-1.58%)

ALGM Allegro MicroSystems
$31.51 /

+0.37 (+1.19%)

ALGM Allegro MicroSystems
$31.51 /

+0.37 (+1.19%)

10/28/22 Mizuho
Allegro MicroSystems price target lowered to $38 from $42 at Mizuho
07/25/22 Barclays
Allegro MicroSystems price target lowered to $26 from $31 at Barclays
05/25/22 Cowen
Allegro MicroSystems initiated with an Outperform at Cowen
05/11/22 Mizuho
Allegro MicroSystems price target lowered to $42 from $44 at Mizuho
SMTC Semtech
$29.36 /

-0.47 (-1.58%)

12/01/22 Cowen
Semtech price target lowered to $33 from $43 at Cowen
12/01/22 Benchmark
Semtech price target lowered to $45 from $65 at Benchmark
12/01/22 Susquehanna
Semtech price target lowered to $32 from $34 at Susquehanna
11/30/22 Piper Sandler
Semtech price target lowered to $45 from $60 at Piper Sandler
SMTC Semtech
$29.36 /

-0.47 (-1.58%)

ALGM Allegro MicroSystems
$31.51 /

+0.37 (+1.19%)

SMTC Semtech
$29.36 /

-0.47 (-1.58%)

SMTC Semtech
$29.36 /

-0.47 (-1.58%)

Hot Stocks
TPI Composites announces restructuring plan, to reduce global headcount by 18% » 17:12
12/02/22
12/02
17:12
12/02/22
17:12
TPIC

TPI Composites

$12.23 /

+0.68 (+5.89%)

In a regulatory filing,…

In a regulatory filing, the company stated, "On December 2, TPI Composites committed to a restructuring plan in order to rebalance the organization and optimize its global manufacturing footprint. In connection with the plan, and as previously announced on November 3, 2022 in our Quarterly Report on Form 10-Q for the quarter ended September 30, 2022, the company intends to cease production at its Yangzhou, China manufacturing facility. The company will reduce its global headcount by approximately 18%, primarily in geographies most impacted by demand. The company will take action under the restructuring plan beginning in December 2022. The company currently estimates that it will recognize pre-tax charges to its 2022 financial results of approximately $45 to $60 million, consisting primarily of costs to shut down the Yangzhou manufacturing facility, severance and other one-time termination benefits, real estate-related charges, contract-related asset impairments and other costs. These charges are expected to include cash charges ranging from $24 to $27 million and will be primarily paid in 2023. The company also expects to incur a total of approximately $45 million of contract related costs in excess of the estimated remaining revenue to complete a contract through June 2024. The company expects to recognize approximately $30 million of these costs in 2023 and $15 million in 2024. These excess costs relate to a supply agreement we entered into in July 2021, pursuant to which we took over the production at a customer's existing manufacturing facility in Matamoros, Mexico. As part of our restructuring plan, we have committed to complete the supply agreement through June 2024, at which time the facility will revert back to the customer. However, we will continue to explore opportunities and options, including potentially amending the contract, to reduce or minimize the impact on our results of operations. The company may incur other charges or cash expenditures not currently contemplated due to unanticipated events that may occur as a result of or in connection with the implementation of the restructuring plan. The company intends to exclude the charges associated with the restructuring plan from its non-GAAP financial measures."

ShowHide Related Items >><<
TPIC TPI Composites
$12.23 /

+0.68 (+5.89%)

TPIC TPI Composites
$12.23 /

+0.68 (+5.89%)

11/04/22 Craig-Hallum
TPI Composites upgraded to Buy from Hold at Craig-Hallum
11/04/22 Craig-Hallum
TPI Composites upgraded to Buy from Hold at Craig-Hallum
10/20/22 JPMorgan
TPI Composites price target lowered to $24 from $27 at JPMorgan
10/17/22 Piper Sandler
TPI Composites price target lowered to $16 from $17 at Piper Sandler
TPIC TPI Composites
$12.23 /

+0.68 (+5.89%)

TPIC TPI Composites
$12.23 /

+0.68 (+5.89%)

Syndicate
First Wave BioPharma files to sell 12.5M shares of common stock for holders  17:08
12/02/22
12/02
17:08
12/02/22
17:08
FWBI

First Wave BioPharma

/

+

 
ShowHide Related Items >><<
FWBI First Wave BioPharma
/

+

FWBI First Wave BioPharma
/

+

12/01/22 H.C. Wainwright
First Wave BioPharma price target lowered to $4 from $8 at H.C. Wainwright
05/26/22 Roth Capital
First Wave BioPharma price target lowered to $9 from $20 at Roth Capital
12/07/21 Maxim
First Wave BioPharma downgraded to Hold from Buy at Maxim
12/07/21 Maxim
First Wave BioPharma downgraded to Hold from Buy at Maxim
Hot Stocks
Momentus announces resignation of CFO Jikun Kim » 17:04
12/02/22
12/02
17:04
12/02/22
17:04
MNTS

Momentus

$1.10 /

-0.02 (-1.79%)

Momentus announced that…

Momentus announced that Jikun Kim, Momentus CFO, will resign from his role effective January 6, 2023. Momentus will announce a successor for Kim at a later date. Kim joined Momentus in September 2020 as CFO. In this role, he led the company's accounting and financial planning and analysis group. He oversaw the company's Special Purpose Acquisition Company transaction that closed in August 2021 and the process of listing Momentus on the NASDAQ exchange.

ShowHide Related Items >><<
MNTS Momentus
$1.10 /

-0.02 (-1.79%)

MNTS Momentus
$1.10 /

-0.02 (-1.79%)

07/05/22 Evercore ISI
Momentus initiated with an Underperform at Evercore ISI
05/23/22 Deutsche Bank
Momentus named short-term buy idea at Deutsche Bank
05/11/22 Deutsche Bank
Momentus price target lowered to $7 from $8 at Deutsche Bank
03/23/22 Deutsche Bank
SpaceX decision 'clear positive' for Momentus, says Deutsche Bank
MNTS Momentus
$1.10 /

-0.02 (-1.79%)

Hot Stocks
Connect Biopharma receives noncompliance notification from Nasdaq » 17:03
12/02/22
12/02
17:03
12/02/22
17:03
CNTB

Connect Biopharma

/

+

Connect Biopharma…

Connect Biopharma announced that, on November 28, it received a letter from the Listings Qualifications Department of the Nasdaq indicating that, for the last 30 consecutive business days, the bid price for the company's American depositary shares had closed below the minimum $1.00 per share requirement for continued listing on the Nasdaq Global Market under Nasdaq Listing Rule 5550.

ShowHide Related Items >><<
CNTB Connect Biopharma
/

+

CNTB Connect Biopharma
/

+

09/14/22 Piper Sandler
Connect Biopharma price target raised to $1.75 from $1.50 at Piper Sandler
06/02/22 Cantor Fitzgerald
Connect Biopharma initiated with an Overweight at Cantor Fitzgerald
05/05/22 Piper Sandler
Connect Biopharma downgraded to Neutral from Overweight at Piper Sandler
01/05/22 Piper Sandler
Connect Biopharma price target lowered to $25 from $31 at Piper Sandler
CNTB Connect Biopharma
/

+

Hot Stocks
AES Corp. raises quarterly dividend 5% to 16.59c per share » 17:00
12/02/22
12/02
17:00
12/02/22
17:00
AES

AES Corp.

$28.67 /

-0.025 (-0.09%)

Payable on February 15,…

Payable on February 15, 2023 to shareholders of record at the close of business on February 1, 2023.

ShowHide Related Items >><<
AES AES Corp.
$28.67 /

-0.025 (-0.09%)

AES AES Corp.
$28.67 /

-0.025 (-0.09%)

12/01/22 Argus
AES Corp. price target raised to $31 from $29 at Argus
11/09/22 Citi
AES Corp. price target raised to $30 from $27 at Citi
11/07/22 Susquehanna
AES Corp. price target raised to $33 from $30 at Susquehanna
08/18/22 Morgan Stanley
AES Corp. price target raised to $32 from $29.50 at Morgan Stanley
AES AES Corp.
$28.67 /

-0.025 (-0.09%)

AES AES Corp.
$28.67 /

-0.025 (-0.09%)

AES AES Corp.
$28.67 /

-0.025 (-0.09%)

Get Full Fly Access

Breaking market intelligence sent straight to you
Our team of experts analyze every news story and filter out the noise to deliver real-time market moving news.
Up-to-date information on important industry events
Get real-time updates on events that are moving the market—from conferences and calls to syndicate announcements.
News focused on the companies in your portfolio
Create up to 12 portfolios with 150 stocks each, and see how active they are in market news.